You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
*ST蘇吳(600200.SH):就Regen Biotech,Inc.違約提起仲裁併被受理立案

格隆匯8月11日丨*ST蘇吳(600200.SH)公佈,公司控股孫公司達透醫療器械(上海)有限公司(簡稱“達透醫療”)就RegenBiotech,Inc.違約事項向深圳國際仲裁院提起仲裁,並於2025年8月7日獲得深圳國際仲裁院受理立案。達透醫療仲裁請求確認《獨家代理協議》有效並繼續履行,若上述仲裁請求未得到支持,初步索賠損失人民幣16億元(包括但不限於已經投入的相關市場開發成本損失,因無法向終端客戶供貨而發生的違約損失,以及合同期內可得利益損失等),並保留根據案情進展及其他相關因素對前述索賠金額進行調整的權利。

本次仲裁將按照《深圳國際仲裁院仲裁規則》進行,仲裁結果存在不確定性,同時不排除仲裁被申請人提出仲裁反請求的可能性。目前,公司無法正常繼續銷售AestheFill,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account